MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study ; volume:166 ; number:1 ; day:5 ; month:10 ; year:2024 ; pages:1-9 ; date:12.2024
Acta neurochirurgica ; 166, Heft 1 (5.10.2024), 1-9, 12.2024
- Creator
-
Ghimire, Prajwal
Kamaludin, Ahmad
Palau, Berta F.
Lavrador, Jose P.
Gullan, Richard
Vergani, Francesco
Bhangoo, Ranjeev
Ashkan, Keyoumars
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00701-024-06300-x
- URN
-
urn:nbn:de:101:1-2412202112303.497505028621
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ghimire, Prajwal
- Kamaludin, Ahmad
- Palau, Berta F.
- Lavrador, Jose P.
- Gullan, Richard
- Vergani, Francesco
- Bhangoo, Ranjeev
- Ashkan, Keyoumars
- SpringerLink (Online service)
Other Objects (12)
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma
MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas
Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
Tumorzellgehalt in Glioblastomen : Zu TERT-Promotormutationen, MGMT-Methylierung und prognostischer Bedeutung von 'Reinheit' in GBM
Next generation configuration mgmt: Autonomous Databases
Veränderungen im MGMT-Status von humanen Glioblastomzelllinien
Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma
MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas
Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
Tumorzellgehalt in Glioblastomen : Zu TERT-Promotormutationen, MGMT-Methylierung und prognostischer Bedeutung von 'Reinheit' in GBM
Next generation configuration mgmt: Autonomous Databases
Veränderungen im MGMT-Status von humanen Glioblastomzelllinien
Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma
MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas
Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
Tumorzellgehalt in Glioblastomen : Zu TERT-Promotormutationen, MGMT-Methylierung und prognostischer Bedeutung von 'Reinheit' in GBM
Next generation configuration mgmt: Autonomous Databases
Veränderungen im MGMT-Status von humanen Glioblastomzelllinien